VANCOUVER, British Columbia, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Anfield Energy Inc. (TSX.V: AEC; NASDAQ: AEC; FRANKFURT: 0AD) (“Anfield” or “the Company”) is pleased to announce the completion of a 20-hole, 8,000-foot confirmation drill program at its JD-7 mine, one of the five mines (JD5, JD-6, JD-7, JD-8 and JD-9) which make up the Company’s Paradox Mine Complex. The drill results will be incorporated into a new uranium and vanadium resource report in Q1/26, alongside the additional drilling to be complete ...

MONTVALE, N.J., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today financial results for its 2025 fiscal third quarter ended September 30, 2025. For the quarter, the Company reported net sales of $267.6 million, net earnings of $40.3 million, adjusted EBITDA(a) of $71.4 million, and free cash flow(a) of $50.7 million. Ted Harris, Chairman, President and CEO of Balchem said, “In the third quarter, our company continued to deliver strong growth, fueled by the ongoing market pe ...

NEW YORK, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) today reported financial results for the third quarter of 2025. Third quarter 2025 net revenue1 was $1.3 billion, an increase of 15% over the third quarter of 2024, or up 11% on an organic2 basis. This included Solutions3 revenue growing 15%, or up 10% on an organic basis.Annualized Recurring Revenue (ARR)4 of $3.0 billion increased 10% over the third quarter of 2024, or up 9% on an organic basis. Annualized SaaS revenue increased 12%, ...

SAN DIEGO, Oct. 21, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ:IBIO), an AI-driven innovator of precision antibody therapies, today announced that Cory Schwartz, Ph.D., Director of Research and Early Development at iBio, will deliver an oral presentation at ObesityWeek 2025 November 4-7 in Atlanta. In addition, Martin Brenner, DVM, Ph.D., Chief Executive Officer and Chief Scientific Officer of iBio, will deliver an oral presentation at PEGS Europe 2025 November 11–13 in Lisbon. “We are excited to share add ...

TUCSON, Ariz., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Mister Car Wash, Inc. (NASDAQ: MCW), the nation’s premier car wash company, today announced the acquisition of five Whistle Express locations in Lubbock, Texas currently operated under the Take 5 Car Wash brand. The transaction expands Mister Car Wash’s footprint in the Lubbock market from four to nine convenient locations, establishing a leading market position across the city. Stephens Inc. served as exclusive financial advisor to Whistle Express on the div ...

TALLAHASSEE, Fla., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Capital City Bank Group, Inc. (NASDAQ: CCBG) today reported net income attributable to common shareowners of $16.0 million, or $0.93 per diluted share, for the third quarter of 2025 compared to $15.0 million, or $0.88 per diluted share, for the second quarter of 2025, and $13.1 million, or $0.77 per diluted share, for the third quarter of 2024. QUARTER HIGHLIGHTS (3rd Quarter 2025 versus 2nd Quarter 2025) Income Statement Tax-equivalent net interest incom ...

HAMBURG, Germany, Oct. 21, 2025 (GLOBE NEWSWIRE) -- XCHG Limited (“XCharge” or the “Company”), (Nasdaq: XCH), a global leader in integrated EV charging solutions, today published its 2024 Environmental, Social and Governance Report (the “2024 ESG Report”). The Report highlights XCharge's achievements and transformative progress toward its commitment to innovate beyond charging by delivering smart and scalable solutions that optimize energy efficiency. Key highlights from the 2024 ESG Report: - ESG Achieveme ...

SION-719 is the first NBD1 stabilizer being evaluated in people living with cystic fibrosis Topline data expected in mid-2026 WALTHAM, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein, today announced initiation of th ...

Core Insights - Tonix Pharmaceuticals Holding Corp. announced a poster presentation for Tonmya™ (cyclobenzaprine HCl sublingual tablets) at the 2025 American College of Rheumatology Convergence, highlighting its efficacy in pain reduction and tolerability for fibromyalgia patients [1][3]. Company Overview - Tonix Pharmaceuticals is a fully-integrated biotechnology company with marketed products and a pipeline focused on central nervous system disorders, immunology, immuno-oncology, rare diseases, and infectious diseases [3]. - The company has received FDA approval for Tonmya™, marking the first new prescription medicine for fibromyalgia in over 15 years [3]. - Tonix also markets two treatments for acute migraine in adults and is developing TNX-102 SL for acute stress reaction, major depressive disorder, and other conditions [3]. Product Development - Tonmya™ is indicated for the treatment of fibromyalgia in adults and is a first-in-class, non-opioid analgesic [3][7]. - The company is developing TNX-1500, an Fc-modified humanized monoclonal antibody for organ transplant rejection and autoimmune diseases [3]. - Tonix's infectious disease portfolio includes TNX-801, a vaccine for mpox and smallpox, and TNX-4800, a monoclonal antibody for Lyme Disease prevention [3]. Clinical Presentation - The poster presentation titled "TNX-102 SL, Cyclobenzaprine HCl Sublingual Tablets, Demonstrates Pain Reduction and Favorable Tolerability in Participants With Fibromyalgia" will take place on October 27, 2025, in Chicago, Illinois [3].

RESTON, Va., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge” or the “Company”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, will announce its financial results for the third quarter of fiscal year 2025 on Wednesday, November 5, after the market closes. Lightbridge will host a conference call on Thursday, November 6, at 4:00 p.m. ET with the investment community to discuss the Company’s financial results and provide an update on its fuel development activities. CONFER ...